EastPharma Ltd. reported revenue results for the nine months of 2012. For the period, the company reported revenue of USD 170.8 million, down 14.1% from the same period in 2011 of USD 198.8 million. EastPharma's sales decrease was driven by decreased volumes in DEVA's Human Pharma Products businesses.
1st Jan change | Capi. | |
---|---|---|
+19.27% | 43.18B | |
+24.05% | 23.23B | |
+15.11% | 14.6B | |
+38.36% | 11.5B | |
-7.63% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.31B | |
-2.27% | 4.81B |